ASS1 and nonpapillary renal cell carcinoma: In a recent study, Khare et al. [175] investigated the loss of urea cycle enzymes ASS1 and ASL in ccRCC patients and elucidated the contributions of ASS1 and ASL loss toward ccRCC progression.